People: Dyadic International Inc (DYAI.PK)

DYAI.PK on OTC Markets Group

1.85USD
22 May 2013
Price Change (% chg)

$0.06 (+3.35%)
Prev Close
$1.79
Open
$1.91
Day's High
$1.94
Day's Low
$1.80
Volume
25,580
Avg. Vol
32,044
52-wk High
$2.25
52-wk Low
$0.85

Search Stocks

Summary

Name Age Since Current Position

Mark Emalfarb

 2008 Chairman of the Board, President, Chief Executive Officer

Michael Faby

 2012 Chief Financial Officer, Vice President

Richard Jundzil

 2010 Vice President - Operations

Thomas O'Shaughnessy

 2010 Vice President - Sales & Marketing

Robert Burke

 2008 Director

Frank Gerardi

 2008 Director

Seth Herbst

 2008 Director

Stephen Warner

 72 2004 Director
» Insider Trading

Biographies

Name Description

Mark Emalfarb

 Mr. Mark A. Emalfarb is Chairman of the Board, President, Chief Executive Officer of Dyadic International, Inc., since June 2008. He is the founder of Dyadic. He has been a member of Dyadic’s board of directors since October 2004 and has served as its Chairman as well as President and Chief Executive Officer of Dyadic from October 2004 until April 2007. Since founding the predecessor to Dyadic in 1979, Mr. Emalfarb has led and managed the evolution of Dyadic from its origins as a pioneer and leader in providing ingredients used in the stone-washing of blue jeans to the discovery, development, manufacturing and commercialization of specialty enzymes used in various industrial applications and the development of an integrated technology platform based on Dyadic’s patented and proprietary C1 fungal microorganism. Mr. Emalfarb is an inventor of over 25 U.S. and foreign biotechnology patents and patent applications resulting from discoveries related to the Company’s patented and proprietary C1 fungus, and has been the architect behind its formation of several strategic research and development, manufacturing and marketing relationships with U.S. and international partners. Mr. Emalfarb earned his B.A. degree from the University of Iowa in 1977.

Michael Faby

 Mr. Michael J. Faby is Chief Financial Officer and Vice President of Dyadic International, Inc., since February 2012. Previously he served as Dyadic’s Vice President Finance since joining the company in December 2009. Mr. Faby has over 24 years of financial, accounting and operational experience. Prior to joining the Company, he served in various financial capacities of increasing responsibility for Perry Slingsby Systems, Inc. (f/k/a Perry Tritech Inc.), a multi-national designer and manufacturer of remotely operated vehicles to the international offshore oil and gas, telecommunications, military and defense industries including, most recently, as its Chief Financial Officer. Mr. Faby is on the board of directors of the Palm Beach County Workforce Alliance. Mr. Faby earned his B.S degree in accounting from Florida State University in 1988 and an MBA from the Florida Institute of Technology. Mr. Faby is a certified public accountant in Florida and a member of the American Institute of Certified Public Accountants and the Florida Institute of Certified Public Accountants.

Richard Jundzil

 Mr. Richard H. Jundzil is Vice President - Operations of Dyadic International, Inc., since May 2010. He was Director of Development & Quality since September 2008 and has held various laboratory, quality and regulatory positions of increasing responsibility since joining the company in August 2003. Mr. Jundzil has over 19 years of quality and operations experience in the biotechnology industry. He also is able to use his experience utilizing process engineering and project management fundamentals while managing the production and distribution of Dyadic’s industrial enzyme products. Prior to joining Dyadic, Mr. Jundzil worked for 10 years at Genzyme Corporation as both a researcher and process engineer producing enzymes for patients with rare genetic diseases. Mr. Jundzil earned a certificate as a Biotechnology Technician from Middlesex College in 1993 and also studied biomedical/clinical sciences at Boston University.

Thomas O'Shaughnessy

 Mr. Thomas M. O'Shaughnessy is Vice President - Sales & Marketing of Dyadic International, Inc., since May 2010. Mr. O’Shaughnessy has over 23 years of sales, marketing and business development experience in the chemical industry. He began his career with the General Electric Company where he spent 12 years in various sales and marketing positions of increasing responsibility and leadership. From 1996 to 2002, he served as Business Development Manager at Occidental Chemical Corporation, one of the chemical companies in the United States. For the past eight years prior to joining the Company, Mr. O’Shaughnessy served as the Global Business Manager for Momentive Specialty Chemicals (formerly Hexion Specialty Chemicals), the world’s producer of thermosetting resins, performance adhesives, UV-curable coatings and the building-block chemical, formaldehyde, for various wood and industrial markets. He is Six Sigma certified and earned a B.S. degree in computer sciences with a minor in marketing from Plattsburgh State University in 1982.

Robert Burke

 Dr. Robert D. Burke, M.D., is Director of Dyadic International, Inc., since June 2008. He is a board certified neuroradiologist. Dr. Burke is the founder and, from 1991 until July 2008, was the President of Midtown Imaging, LLC, an imaging center with multiple locations throughout Palm Beach County, Florida. From 1994 to 1996, Dr. Burke was the co-Founder and President of U.S. Diagnostic Inc., a publicly traded national diagnostic imaging company. Dr. Burke is on the board of directors of Stonegate Bank, a publicly traded bank serving Southeast Florida. Dr. Burke also serves on the board of directors and is the President of the Palm Beach County Chapter of the Leukemia & Lymphoma Society. He also is a member of the Scripps Clinic and Research Foundations Board of Scripps Florida. Dr. Burke earned his B.A. degree from the University of Louisville in 1977 and his medical degree from the University of Louisville School of Medicine in 1981. Dr. Burke completed his radiology residency at the University of Chicago and a fellowship in neuroradiology at the University of Rochester.

Frank Gerardi

 Mr. Frank P. Gerardi is Director of Dyadic International, Inc., since June 2008. From February 2007 to the present, Mr. Gerardi has been a managing partner at QuantWorks, LLC, a registered investment advisor. From June 2003 to December 2006, Mr. Gerardi was the Chief Executive Officer of IGI, Inc. (now known as IGI Laboratories, Inc.), a public company that engages in the development, manufacture, filling, and packaging of topical, semi-solid, and liquid products for pharmaceutical, cosmeceutical, and cosmetic companies. Since 1986, he has also served as the President of Univest Management, Inc., a private management consulting company. Mr. Gerardi was a member of the New York Stock Exchange from 1969 to 1986. Mr. Gerardi has served on the boards of numerous New York Stock Exchange member firms and was a registered principal with the National Association of Securities Dealers (NASD). Mr. Gerardi is also on the board of directors of CHS Pharma, Inc., a private biotechnology company in Jupiter, Florida.

Seth Herbst

 Dr. Seth J. Herbst, M.D., is Director of Dyadic International, Inc., since June 2008. He is a board certified obstetrician/gynecologist who is also board certified in advanced laparoscopic and minimally invasive gynecologic surgery. Dr. Herbst is the founder and President of the Institute for Women’s Health and Body, an OB/GYN practice with multiple locations in Palm Beach County, Florida. He is the co-founder of Visions Clinical Research which performs medical and surgical clinical trials throughout the United States. Dr. Herbst is also a consultant for multiple medical device companies in the United States and a member of medical advisory boards for these and other companies. He received his B.S. degree from American University in 1978 and his medical degree from Universidad del Noreste School of Medicine in Tampico, Mexico in 1983. Dr. Herbst completed his OB/GYN residency and was Chief Resident at Long Island College Hospital in Brooklyn, New York.

Stephen Warner

 Mr. Stephen J. Warner is Director of Dyadic International, Inc., since October 2004. He is director of the Company’s wholly owned subsidiary, Dyadic International (USA), Inc. since August 2004. From June 2010 through February 2012, Mr. Warner served as the Chief Financial Officer of Gulfstar Energy Corporation, a public and, later, private oil and gas production company based in Kentucky and has been a member of its board of directors from June 2010 to the present. Mr. Warner has over 30 years of venture capital experience. In 1981, Mr. Warner founded Merrill Lynch Venture Capital Inc., a wholly owned subsidiary of Merrill Lynch & Co. Inc. in New York, and served as its President and Chief Executive Officer from 1981 to 1990. Under his leadership, Merrill Lynch Venture Capital managed over $250 million and made over 50 venture capital investments. From 1999 until 2004, Mr. Warner co-founded and served as Chairman and Chief Executive Officer of Crossbow Ventures Inc., a venture capital and private equity fund that invested in early and expansion stage technology companies primarily located in Florida and the Southeast, with over 20 venture capital investments in Florida. Mr. Warner is on the board of directors of UCT Coatings Inc., a private nickel-based coatings company based in Florida, and Navitas Land & Mineral Corporation, a private oil exploration and production company based in Kentucky. Mr. Warner earned a B.S. degree from the Massachusetts Institute of Technology in 1962 and an MBA from the Wharton School of Business at the University of Pennsylvania in 1966.

Basic Compensation

Name Fiscal Year Total

Mark Emalfarb

 398,765

Michael Faby

 --

Richard Jundzil

 --

Thomas O'Shaughnessy

 --

Robert Burke

 --

Frank Gerardi

 --

Seth Herbst

 --

Stephen Warner

 --
As Of 30 Dec 2006

Options Compensation

Name Options Value

Mark Emalfarb

 0 0

Michael Faby

 0 0

Richard Jundzil

 0 0

Thomas O'Shaughnessy

 0 0

Robert Burke

 0 0

Frank Gerardi

 0 0

Seth Herbst

 0 0

Stephen Warner

 0 0

Insider Trading

» Full list on Insider Trading
Search Stocks